MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.